Merck
€134.45Change from previous close: −2.64%Absolute change: −€3.65
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 21,102 | 21,156 | 20,993 | 22,232 | 19,687 |
| Cost of revenue | 8,673 | 8,630 | 8,557 | 8,500 | 7,325 |
| Gross profit | 12,429 | 12,526 | 12,436 | 13,732 | 12,362 |
| Selling, general and administrative | 5,946 | 5,794 | 5,674 | 5,989 | 5,458 |
| Research and development | 2,385 | 2,268 | 2,438 | 2,447 | 2,418 |
| Operating income | 3,930 | 4,210 | 3,836 | 4,978 | 4,306 |
| EBIT | 3,930 | 4,210 | 3,836 | 4,978 | 4,306 |
| EBITDA | 5,700 | 5,906 | 5,514 | 6,522 | 5,788 |
| Interest expense | 326 | 229 | 260 | 196 | 245 |
| Pre-tax income | 3,308 | 3,537 | 3,484 | 4,288 | 3,924 |
| Income tax | 693 | 751 | 650 | 948 | 859 |
| Net income | 2,608 | 2,777 | 2,824 | 3,326 | 3,055 |
| Net income to common shareholders | 2,608 | 2,777 | 2,824 | 3,326 | 3,055 |
| Basic EPS | 6.00 | 6.39 | 6.50 | 7.65 | 7.03 |
| Diluted EPS | 6.00 | 6.39 | 6.49 | 7.65 | 7.03 |
| Average shares (basic) | 435 | 435 | 435 | 435 | 435 |
| Average shares (diluted) | 435 | 435 | 435 | 435 | 435 |
| Dividend per share | 2.20 | 2.20 | 2.20 | 2.20 | 1.85 |